Real-world data for effectiveness and safety of palopegteriparatide in patients with chronic hypoparathyroidism: the PaTH REAL study.

Yavropoulou MP, Tournis S, Chondrogianni ME, Florakis D, Chrisoulidou A, Adamidou F, Efstathiadou Z, Giagourta E, Giannou A, Stratigou T, Markou A, Vasileiou V, Ntali G, Balodimou C, Kalogeris N, Koloutsou ME, Makras P, Vryonidou A, Kassi E

Open source

DOI: 10.1093/ejendo/lvag145
Published: 2026 Aug 3
Container: European journal of endocrinology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ejendo/lvag145,
  title = {Real-world data for effectiveness and safety of palopegteriparatide in patients with chronic hypoparathyroidism: the PaTH REAL study.},
  author = {Yavropoulou MP and Tournis S and Chondrogianni ME and Florakis D and Chrisoulidou A and Adamidou F and Efstathiadou Z and Giagourta E and Giannou A and Stratigou T and Markou A and Vasileiou V and Ntali G and Balodimou C and Kalogeris N and Koloutsou ME and Makras P and Vryonidou A and Kassi E},
  year = {2026},
  journal = {European journal of endocrinology},
  doi = {10.1093/ejendo/lvag145},
  url = {https://doi.org/10.1093/ejendo/lvag145}
}

RIS

TY  - JOUR
TI  - Real-world data for effectiveness and safety of palopegteriparatide in patients with chronic hypoparathyroidism: the PaTH REAL study.
AU  - Yavropoulou MP
AU  - Tournis S
AU  - Chondrogianni ME
AU  - Florakis D
AU  - Chrisoulidou A
AU  - Adamidou F
AU  - Efstathiadou Z
AU  - Giagourta E
AU  - Giannou A
AU  - Stratigou T
AU  - Markou A
AU  - Vasileiou V
AU  - Ntali G
AU  - Balodimou C
AU  - Kalogeris N
AU  - Koloutsou ME
AU  - Makras P
AU  - Vryonidou A
AU  - Kassi E
PY  - 2026
JO  - European journal of endocrinology
DO  - 10.1093/ejendo/lvag145
UR  - https://doi.org/10.1093/ejendo/lvag145
ER  -

APA

MP, Y., S, T., ME, C., D, F., A, C., F, A., Z, E., E, G., A, G., T, S., A, M., V, V., G, N., C, B., N, K., ME, K., P, M., A, V., & E, K. (2026). Real-world data for effectiveness and safety of palopegteriparatide in patients with chronic hypoparathyroidism: the PaTH REAL study.. European journal of endocrinology. https://doi.org/10.1093/ejendo/lvag145

Source records

pubmed · retrieved 2026-09-25T20:23:51.139Z